The First Trust Mid Cap Growth AlphaDEX Fund ETF (FNY) shows an implied analyst target price of $95.91, suggesting a 10.96% upside from its recent $86.44 trading price, based on the weighted average of analyst targets for its underlying holdings. This potential is notably driven by key constituents such as Samsara Inc (IOT), ACI Worldwide Inc (ACIW), and Globus Medical Inc (GMED), which analysts project to have substantial individual upsides of 42.33%, 36.60%, and 33.94% respectively. This analysis highlights significant perceived growth potential within FNY's portfolio, prompting investors to evaluate the current validity and justification of these analyst targets.
Based on a weighted average of its underlying holdings' 12-month forward price targets, the First Trust Mid Cap Growth AlphaDEX Fund ETF (FNY) shows an implied analyst upside of 10.96%, with a target of $95.91 per unit against a recent trading price of $86.44. This potential is significantly influenced by a few key constituents with substantial projected gains. Specifically, analysts forecast a 42.33% upside for Samsara Inc (IOT), 36.60% for ACI Worldwide Inc (ACIW), and 33.94% for Globus Medical Inc (GMED). While these figures highlight strong optimism within the analyst community for specific mid-cap growth names, the article appropriately questions whether these targets are justified or potentially outdated. The analysis, therefore, centers on an opportunity identified through consensus estimates, but one that is contingent on the validity of highly optimistic forecasts for a concentrated set of the ETF's holdings.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.50
Ticker Sentiment
